Evidence map›Paper›PMID 27548160›Full record

ArticleInternational journal of molecular sciences2016

Inflammatory Cutaneous Diseases in Renal Transplant Recipients.

Paola Savoia, Giovanni Cavaliere, Elisa Zavattaro, Federica Veronese, Paolo Fava

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Paola SavoiaDepartment of Health Sciences, "A. Avogadro" University of Eastern Piedmont, 28100 Novara, Italy. paola.savoia@med.uniupo.it.
Giovanni CavaliereDepartment of Medical Science, University of Turin, 10126 Turin, Italy. g.cavali_dr@yahoo.it.
Elisa ZavattaroDepartment of Health Sciences, "A. Avogadro" University of Eastern Piedmont, 28100 Novara, Italy. elisa.zavattaro@med.uniupo.it.
Federica VeroneseDepartment of Health Sciences, "A. Avogadro" University of Eastern Piedmont, 28100 Novara, Italy. federica.veronese@med.uniupo.it.
Paolo FavaDepartment of Medical Science, University of Turin, 10126 Turin, Italy. fava_paolo@yahoo.it.
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney transplant recipients frequently suffer from skin infections and malignancies, possibly due to the effects of long-term immunosuppressive therapy. While the relationships between immunosuppression and these pathological conditions have been widely investigated, little is known about the relative incidence and characteristics of inflammatory skin diseases in this type of patient. In this study, we analyze the incidence of a number of inflammatory cutaneous diseases in a cohort of patients who underwent kidney transplantation. Although our study shows a relatively low incidence of these pathologies in transplanted patients-in agreement with the general action of immunosuppressant therapies in reducing inflammation-we scored a different efficacy of the various immunosuppressive regimens on inflammatory and autoimmune skin diseases. This information can be key for designing immunosuppressive regimens and devising accurate follow-up protocols.

Indexed as

EverolimusHumansImmunosuppressive AgentsInflammationKidney TransplantationMaleMiddle AgedSirolimusSkin DiseasesTransplant RecipientsEverolimusImmunosuppressive AgentsSirolimuscutaneous diseasesinflammatorykidney transplantation

Identifiers

PMID27548160
PMCPMC5000757
OpenAlexW2517249743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.